Director Dealing

Director Dealing

Manchester, UK – 16 April 2019 – SkinBioTherapeutics plc (AIM: SBTX – “SkinBioTherapeutics” or the “Company”), a life science company focused on skin health, announces it was notified on 15 April 2019, that Dr Cathy Prescott, a Non-Executive Director of the Company, acquired 56,112 ordinary shares on 15 April 2019 at a price of 17.82p per share.

 

Dr Prescott now holds 56,112 ordinary shares in the Company, representing 0.04% of the Company's issued share capital.

 

16th April, 2019
investors logo